Isis regulatory update

Patent No. 5,506,212 covers chiral forms of antisense compounds directed toward human papilloma virus.

Patent No. 5,521,302 covers methods for

Read the full 208 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE